330 related articles for article (PubMed ID: 15979312)
1. Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade.
Ophir G; Amariglio N; Jacob-Hirsch J; Elkon R; Rechavi G; Michaelson DM
Neurobiol Dis; 2005 Dec; 20(3):709-18. PubMed ID: 15979312
[TBL] [Abstract][Full Text] [Related]
2. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
Levi O; Dolev I; Belinson H; Michaelson DM
J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
[TBL] [Abstract][Full Text] [Related]
3. Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice.
Ophir G; Meilin S; Efrati M; Chapman J; Karussis D; Roses A; Michaelson DM
Neurobiol Dis; 2003 Feb; 12(1):56-64. PubMed ID: 12609489
[TBL] [Abstract][Full Text] [Related]
4. Implications of apolipoprotein E genotype on inflammation and vitamin E status.
Huebbe P; Lodge JK; Rimbach G
Mol Nutr Food Res; 2010 May; 54(5):623-30. PubMed ID: 20183830
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E genotype and alpha-tocopherol modulate amyloid precursor protein metabolism and cell cycle regulation.
Huebbe P; Schaffer S; Jofre-Monseny L; Boesch-Saadatmandi C; Minihane AM; Müller WE; Eckert GP; Rimbach G
Mol Nutr Food Res; 2007 Dec; 51(12):1510-7. PubMed ID: 18030662
[TBL] [Abstract][Full Text] [Related]
6. Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior.
Grootendorst J; Bour A; Vogel E; Kelche C; Sullivan PM; Dodart JC; Bales K; Mathis C
Behav Brain Res; 2005 Apr; 159(1):1-14. PubMed ID: 15794991
[TBL] [Abstract][Full Text] [Related]
7. Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology.
Hartman RE; Wozniak DF; Nardi A; Olney JW; Sartorius L; Holtzman DM
Exp Neurol; 2001 Aug; 170(2):326-44. PubMed ID: 11476599
[TBL] [Abstract][Full Text] [Related]
8. An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction.
Wang H; Durham L; Dawson H; Song P; Warner DS; Sullivan PM; Vitek MP; Laskowitz DT
Neuroscience; 2007 Feb; 144(4):1324-33. PubMed ID: 17187933
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E-genotype dependent hippocampal and cortical responses to traumatic brain injury.
Crawford F; Wood M; Ferguson S; Mathura V; Gupta P; Humphrey J; Mouzon B; Laporte V; Margenthaler E; O'Steen B; Hayes R; Roses A; Mullan M
Neuroscience; 2009 Apr; 159(4):1349-62. PubMed ID: 19409232
[TBL] [Abstract][Full Text] [Related]
10. Brain area- and isoform-specific inhibition of synaptic plasticity by apoE4.
Levi O; Jongen-Relo AL; Feldon J; Michaelson DM
J Neurol Sci; 2005 Mar; 229-230():241-8. PubMed ID: 15760646
[TBL] [Abstract][Full Text] [Related]
11. Environmental enrichment stimulates neurogenesis in apolipoprotein E3 and neuronal apoptosis in apolipoprotein E4 transgenic mice.
Levi O; Michaelson DM
J Neurochem; 2007 Jan; 100(1):202-10. PubMed ID: 17074063
[TBL] [Abstract][Full Text] [Related]
12. Effect of apoE genotype and vitamin E on biomarkers of oxidative stress in cultured neuronal cells and the brain of targeted replacement mice.
Huebbe P; Jofre-Monseny L; Boesch-Saadatmandi Ch; Minihane AM; Rimbach G
J Physiol Pharmacol; 2007 Dec; 58(4):683-98. PubMed ID: 18195481
[TBL] [Abstract][Full Text] [Related]
13. Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease.
Xu PT; Li YJ; Qin XJ; Scherzer CR; Xu H; Schmechel DE; Hulette CM; Ervin J; Gullans SR; Haines J; Pericak-Vance MA; Gilbert JR
Neurobiol Dis; 2006 Feb; 21(2):256-75. PubMed ID: 16198584
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice.
Sheng H; Laskowitz DT; Bennett E; Schmechel DE; Bart RD; Saunders AM; Pearlstein RD; Roses AD; Warner DS
J Cereb Blood Flow Metab; 1998 Apr; 18(4):361-6. PubMed ID: 9538900
[TBL] [Abstract][Full Text] [Related]
15. Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks.
Bour A; Grootendorst J; Vogel E; Kelche C; Dodart JC; Bales K; Moreau PH; Sullivan PM; Mathis C
Behav Brain Res; 2008 Nov; 193(2):174-82. PubMed ID: 18572260
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling.
Colangelo V; Schurr J; Ball MJ; Pelaez RP; Bazan NG; Lukiw WJ
J Neurosci Res; 2002 Nov; 70(3):462-73. PubMed ID: 12391607
[TBL] [Abstract][Full Text] [Related]
17. Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology.
Wang C; Wilson WA; Moore SD; Mace BE; Maeda N; Schmechel DE; Sullivan PM
Neurobiol Dis; 2005 Mar; 18(2):390-8. PubMed ID: 15686968
[TBL] [Abstract][Full Text] [Related]
18. ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42.
Trommer BL; Shah C; Yun SH; Gamkrelidze G; Pasternak ES; Stine WB; Manelli A; Sullivan P; Pasternak JF; LaDu MJ
Neurobiol Dis; 2005 Feb; 18(1):75-82. PubMed ID: 15649697
[TBL] [Abstract][Full Text] [Related]
19. The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol.
Kariv-Inbal Z; Yacobson S; Berkecz R; Peter M; Janaky T; Lütjohann D; Broersen LM; Hartmann T; Michaelson DM
J Alzheimers Dis; 2012; 28(3):667-83. PubMed ID: 22057027
[TBL] [Abstract][Full Text] [Related]
20. Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion.
White F; Nicoll JA; Roses AD; Horsburgh K
Neurobiol Dis; 2001 Aug; 8(4):611-25. PubMed ID: 11493026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
